Drug firm grows with acquisition
Print Edition
SHANGHAI Fosun Pharmaceutical has agreed to fully acquire French drug distributor Tridem for 63 million euros (US$73 million) as the Chinese conglomerate takes another step in its international expansion.
The Chinese drug maker, a unit of Shanghai-headquartered conglomerate Fosun International, said in a statement yesterday that it will buy shares in Tridem from existing shareholders including Financière des Lices, Multicroissance, and a French fund FCPR PMC II.
Fosun Pharmaceutical will have the right to nominate at least four directors to sit on Tridem's board while Financière des Lices shall have the right to nominate one director.
The French company is the third-largest pharma distribution company in French-speaking Africa with a sales network covering 21 countries and regions, according to a stock exchange filing.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
